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AbstrAct
Objectives:  Lactoferrin  (LF)  is  an  iron  binding  protein  and  stored  in  the  specific  granules  of 
granulocytes. It is released by degranulation following granulocyte activation. A positive correlation 
was previously reported between periodontitis and LF titers of gingival crevicular fluid (GCF) and 
blood. The purpose of this study was to examine alterations of GCF and blood levels of LF (LF-GCF 
and LF-BL, respectively), employing the experimental gingivitis model.
Methods: Twelve systemically healthy volunteers, aged 19-21, were selected.  Pre-experimental 
phase of hygiene was followed by a 14-day experimental gingivitis phase in which subjects refrained 
from all oral hygiene procedures. After that subjects resumed optimal plaque control for 21 days of 
recovery period. At days 0 (baseline), 14 and 35 gingival crevicular fluid (GCF) and blood samples were 
collected and plaque index (PI), gingival index (GI), bleeding on probing (BOP) and probing pocket depth 
scores were recorded. LF levels were measured with commercial enzyme-linked immunosorbent 
assay (ELISA) kit. 
Results: PI, GI, BOP and LF-GCF increased significantly after 14 days of experimental gingivitis 
period  and  decreased  significantly  after  reinstitution  of  oral  hygiene  measures  (P<.05).  LF-BL 
appeared to follow the same pattern. Significant negative correlation was detected between the level 
of LF-BL and BOP at day 14 (P<.05), whereas significant positive correlation was noticed between LF-
BL and clinical scores PI, GI and BOP at day 35 (P<.05).
Conclusions:  LF-BL  followed  the  same  pattern  with  LF-GCF  and  clinical  scores  during  the 
experimental gingivitis and recovery periods, although alterations of the LF-BL appeared statistically 
insignificant. (Eur J Dent 2009;3:16-23)
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The periodontal diseases has complex etiology 
and has been proposed that it is the host response 
to  the  long-term  bacterial  challenge,  including 
increased neutrophil response and the release of 
proinflammatory mediators, which may be related 
with  initiation  and  exacerbation  of  the  systemic 
diseases  and  conditions.  When  compared  to 
periodontally healthy subjects, significantly higher 
plasma  white  cell  counts  has  been  reported 
for  subjects  with  gingivitis  and  periodontitis, 
and suggested that those high white cell counts 
might be related with systemic diseases such as 
myocardial infarction.1 Neutrophilic granulocytes 
play an important role at the primary defense of 
the  host  against  pathogens  and  immunogenic 
materials.2  They  are  reported  to  be  present  in 
increased numbers within the gingival pocket and 
to be the predominant leukocytes in the pocket 
epithelium  and  adjacent  connective  tissue  in 
periodontal diseases.3-5 
Lactoferrin (LF), an iron binding protein with 
some  antibacterial  properties  is  stored  in  the 
specific (secondary) granule of the granulocytes 
and  mainly  released  during  migration  and 
influences granulocyte functions such as adhesion 
and  chemotaxis.3,6  LF  has  been  proposed  as  a 
marker of the number of granulocytes.7 Following 
the  activation  of  neutrophils,  degranulation  of 
specific granules with an instantaneous release 
of  LF,  has  been  demonstrated  previously.6,7  LF 
titers in various body fluids, including sputum and 
blood,  were  reported  to  be  correlated  with  the 
presence of inflammation, such as periodontitis.8 
Significantly higher levels of LF-GCF have been 
found at both periodontitis and gingivitis compared 
to healthy sites and those titers also reported to 
be degreased to the healthy sites’ LF levels after 
periodontal treatment.9,10 
The human experimental gingivitis study model, 
introduced by Löe et al,4 has shown that qualitative 
effect of dental plaque created by total withdrawal 
of  oral  hygiene  procedures  leads  to  gingival 
inflammation  and  since  this  pioneering  work  of 
Löe  et  al,  many  studies  have  been  undertaken 
using experimental gingivitis study model.11-14 
The purpose of our present study was to examine 
the alterations of LF levels in GCF and peripheral 
venous blood, resulting from the bacterial plaque 
accumulation in a healthy mouth, employing the 
experimental gingivitis model, in order to examine 
whether  local  gingival  inflammation  has  some 
systemic influence.
MAtErIALs And MEtHods
Patient selection 
Twelve  dental  students  attending  Gazi 
University  Faculty  of  Dentistry  was  recruited 
voluntarily. This participant group consisted of all 
systemically healthy males in age ranging from 19 
to 21 years. They were selected on the presence 
of 24 teeth or more, absence of pockets ≥ 5 mm 
and  absence  of  approximal  attachment  loss.15,16 
No  subject  wore  any  orthodontic  or  prosthetic 
appliances.17 The use of any medication that might 
interfere  with  the  outcome  of  the  study,  during 
the  past  6  months,  was  an  exclusion  criterion, 
such as anti-inflammatory agents, antibiotics, and 
immunosuppressive drugs. All of the participants 
were  non-smokers.  The  study  protocol  was 
approved  by  Institutional  Review  Board  at  Gazi 
University,  School  of  Medicine  and  all  subjects 
were asked to give an informed written consent 
to participate, after a thorough explanation of the 
procedures and objectives of the study.
Experimental design
Experimental design of the study consisted of 
3  parts  as  pre-experimental,  experimental  and 
recovery periods (Figure 1):
•  Pre-experimental  period:  Two  weeks  prior 
to the experimental period participants received a 
thorough dental prophylaxis and instruction in oral 
hygiene. During the following week professional 
tooth  cleaning  was  repeated.  Participants  were 
regularly  examined  and  their  oral  hygiene  was 
monitored  to  achieve  maximum  gingival  health. 
When participants had less than 20% approximal 
bleeding sites, they entered a 14 day experimental 
gingivitis trial period.15,16
• Experimental period: Examiners made sure 
of the participants gingival health at the baseline 
of this period via clinical indices, then participants 
were led to enter this period by cessation of all 
plaque control measures.15,16 At day 0 (baseline) 
and  14  clinical  parameters  were  recorded,  and 
peripheral venous blood and GCF samples were 
taken.
IntroductIon
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• Recovery period: After 14 day experimental 
period  without  any  oral  hygiene  measures, 
participants  received  professional  prophylaxis, 
instruction  in  oral  hygiene  and  they  were 
encouraged  to  return  their  daily  oral  hygiene 
measures.  The  professional  tooth  cleaning  was 
repeated  and  periodontal  condition  regularly 
examined in order to achieve maximum gingival 
health during this 21-day recovery period.5 At the 
end of the 21 day recovery period clinical indices 
were repeated and peripheral venous blood and 
GCF samples were taken.
Periodontal examination
Following clinical parameters were recorded for 
monitoring the gingival situation of the participants 
before  and  during  the  experimental  period  and 
control period: Plaque index (PI),18 gingival index 
(GI),19  bleeding  on  probing  (BOP)20  and  probing 
pocket depth (PD). All clinical parameters were 
measured  with  a  William’s  probe  calibrated  in 
millimeters. 
GCF sampling 
For  collection  of  GCF,  prefabricated  sterile 
paper  strips  (Periopaper®  GCF  Strips,  Proflow, 
Amityville, NY) were used. The sites to be sampled 
 Lactoferrin in gingival crevicular fluid
Figure 1. Experimental design of the study. Figure 2. Plaque index (*: P<.05).
Figure 3. Gingival Index (*: P<.05). Figure 4. Bleeding on probing (*: P<.05).
Figure 5. Pocket depth. Figure 6. The levels of lactoferrin in GCF (LF-GCF) and blood 
(LF-BL) (*: P<.05).January 2009 - Vol.3
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were  isolated  with  cotton  rolls  and  visible 
supragingival  plaque  was  removed  carefully  by 
cotton  pellets.  The  area  was  gently  air-dried  in 
an apico-coronal direction and 30 sec. later paper 
strips were inserted into the gingival crevice until 
mild resistance was felt and left there for 30 sec.21 
Strips  contaminated  by  dental  plaque,  saliva, 
bleeding or exudates were discarded. Strips were 
stored  in  a  labeled  microcentrifuge  tube  and 
frozen at -70ºC until further processing. Prior to 
assaying strips were eluted into 300 µl of 20mM 
phosphate buffer, pH 6.0, containing 0.15 M NaCl 
and 0.1% Tween 20.22
Blood sampling
Six milliliters of peripheral venous blood was 
drawn into glass test tubes that contain EDTA as 
an anticoagulant. After the separation of plasma, 
the  samples  were  stored  at  -70ºC  until  further 
processing.
Lactoferrin levels
LF levels were determined by a commercial 
ELISA  kit  (Calbiochem,  Darmstad,  Germany)  as 
described  in  the  manufacturer’s  instructions. 
Different  concentrations  of  LF  (100,  50,  25, 
12.5,  6.2,  3.1,  1.6  ng/μl)  were  prepared  by  the 
dilution  of  lyophilized  LF  standard,  supplied 
by  the  manufacturer.  The  absorbance  values 
(Optical  Densities=OD)  were  measured 
spectrophotometrically  at  a  wavelength  of  450 
nm, and the results were evaluated quantitatively 
according to the ODs of standard LF concentrations. 
If the measured concentrations of LF in a sample 
were greater then 100 ng/ml, the sample was re-
tested by using further dilutions (1/100).
Statistical analysis 
The  clinical  parameters,  LF-GCF  and  LF-
BL  were  expressed  as  mean±standard  error. 
Repeated measurement variance analysis (ANOVA) 
was used for assessment of the data obtained at 
day 0, 14 and 35.23 The arc-sinus transformation 
was used for ANOVA assessments of BOP data. 
Bonferroni  test  was  used  for  determination  of 
different groups. The Pearson test was used for 
correlation assessments.23
rEsuLts
Clinical parameters
The  mean  clinical  parameters  and  their 
standard errors are summarized in Figures 2-5. PI, 
GI and BOP scores showed statistically significant 
increase during the experimental period of 14 days 
and significant decrease thereafter, as expected 
(P<.01).  Pearson  correlation  and  P  values  are 
summarized at Tables 1 and 2. 
Lactoferrin levels
The mean data of LF levels (±standard errors) 
in  GCF  (LF-GCF)  and  blood  (LF-BL)  and  their 
standard deviations are summarized at Figure 6. 
The differences between mean LF-GCF levels 
for time intervals found to be statistically significant 
(P<.01). From day 0 to day 14, mean LF-GCF levels 
significantly  increased  (58.8±7.2  and  163.2±21.9 
ng/μl, respectively) (Min: 29 ng/μl, Max: 98 ng/μl 
and min: 72 ng/μl, max: 297 ng/μl, respectively) 
(P<.05),  and  significantly  decreased  at  day  35 
(58.7±5.4  ng/μl)  (Min:  26  ng/μl,  Max:  191  ng/μl) 
(P<.05).  The  pattern  of  LF-GCF  levels  followed 
during all of the periods of the study appeared to 
be similar and compatible with pattern of PI, GI and 
BOP scores, although no statistically significant 
correlation was detected (Tables 1 and 2). 
The mean level of LF-BL at day 0 which was 
detected as 112.0±23.4 ng/μl (Min: 1 ng/μl, Max: 
255 ng/μl), was increased to 200.0±22.9 ng/μl (Min: 
7 ng/μl, Max: 289 ng/μl) at day 14 and decreased 
to 125.0±27.5 ng/μl (Min: 9 ng/μl, Max: 256 ng/μl) 
at day 35. No statistically significant differences 
were found between the time intervals. Levels of 
LF-BL  demonstrated  almost  the  same  pattern 
with LF-GCF, PI, GI and BOP at days 0, 14 and 35. 
However, a significant negative correlation existed 
between  the  level  of  LF-BL  and  BOP  at  day  14 
(P<.05),  whereas  significant  positive  correlation 
existed between the level of LF-BL and scores of 
PI, GI and BOP at day 35 (P<.05) (Tables 1 and 2).
dIscussIon
In the present study it was aimed to examine 
previously  hypothesized  systemic  inflammatory 
response triggered by dental plaque accumulation 
via assessment of neutrophil protease LF levels 
within GCF and peripheral venous blood, employing 
the experimental gingivitis model. Kowolik et al5 
demonstrated  that  circulating  neutrophils  were 
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gradually  increased  during  the  experimental 
gingivitis period of 21 days and they stated that 
results of their study support the hypothesis that 
the accumulation of dental plaque can result in a 
measurable systemic inflammatory response. 
The present study, intentionally, consisted of 
solely male, systemically healthy and non-smoker 
dental student volunteers of the same age group. 
It  has  been  reported  that  hormonal  influences 
caused by gender differences and age may alter the 
response to the bacterial challenge.5,24,25 Smoking 
has previously been associated with etiology and 
pathogenesis of the periodontal diseases and also 
with the outcomes of the periodontal treatments.26-
28 Smoking has also been reported to have adverse 
effects on PMN viability and function within GCF of 
periodontally healthy population.29 
Human experimental gingivitis, which was first 
introduced  almost  half  century  ago,  is  still  one 
of the most preferred model for researchers to 
investigate the nature of periodontal diseases.24,30 
The  clinical  scores  of  the  present  study  was 
consistent with the previous studies recruiting the 
experimental study model.13,16  
In GCF, significantly higher levels of LF have 
been  found  at  both  periodontitis  and  gingivitis 
sites  compared  to  healthy  sites.9  On  the  other 
hand,  Gustafsson  et  al3  reported  that  the  LF-
GCF did not differ significantly between gingivitis, 
periodontitis with/without destruction and authors 
claimed that LF-GCF levels were not related to the 
local severity of the periodontal disease. 
In  our  present  study,  LF-GCF  increased 
significantly  during  the  course  of  the  plaque 
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  PI PPD GI BOP LF-BL
PPD
0.241*
0.451†
GI
0.334 0.290
0.289 0.361
BOP
0.361 0.189 0.790
0.250 0.557 0.002
LF-BL
-0.243 -0.169 -0.502 -0.730
0.447 0.599 0.097 0.007
LF-GCF
-0.032 0.318 0.146 -0.064 0.390
0.922 0.314 0.651 0.843 0.210
* : Pearson correlation (r). 
† : P value.
* : Pearson correlation (r). 
† : P value.
Table 1. Pearson correlation between PI, PPD, GI, BOP, LF-BL AND LF-GCF at day-14.
Table 2. Pearson correlation between PI, PPD, GI, BOP, LF-BL AND LF-GCF at day-35.
  PI PPD GI BOP LF-BL
PPD
0.377*
0.227†
GI
0.593 0.492
0.042 0.104
BOP
0.353 0.562 0.610
0.260 0.057 0.035
LF-BL
0.630 0.543 0.608 0.650
0.028 0.068 0.036 0.022
LF-GCF
-0.152 -0.217 -0.272 -0.541 -0.517
0.638 0.498 0.392 0.069 0.086January 2009 - Vol.3
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accumulation period which is in agreement with 
the findings of Fransson et al.24 In that study of 
Fransson et al,24 a very similar protocol, with a 
similar age group (aged 20-25 years) of participants, 
was followed as in our present study; however the 
experimental period was longer (21 days). A strong 
agreement was found between the two studies by 
the means of LF-GCF increase from day 0 to 14th 
day of the experimental gingivitis period. Fransson 
et al24 reported that LF-GCF increased 2,2 times 
after 14 days of plaque accumulation (125 ng/μl to 
277 ng/μl) , which is quite close to our findings that 
indicate 2.8 times increase of LF-GCF from day 0 
to 14 (58.8±7.2 ng/μl to 163.2±21.9 ng/μl).24 
The  results  of  this  study  also  showed  that 
GCF-LF  levels  decreased  significantly  after 
the  reinstitution  of  oral  hygiene  measures  and 
approached the levels that observed at baseline 
day  0.  This  probably  reflects  the  decreasing  of 
neutrophil  chemotactic  factors  in  the  crevice 
following  plaque  elimination  and  resolution  of 
inflammation.  This  is  in  agreement  with  the 
results of an earlier study by Adonogianaki et al.31 
Authors  examined  four  acute-phase  proteins, 
including LF, in GCF during the course of a 21 day 
experimental gingivitis study and reported that the 
concentrations of LF were significantly elevated 
during  the  course  of  the  trial  and  when  plaque 
control was reestablished these values declined. 
It  has  also  been  suggested  previously  that  LF-
GCF might be a suitable marker for monitoring 
of  treatment  effects  in  periodontal  disease, 
particularly periodontitis.32,33 
Previous  studies  have  pointed  out  a  positive 
correlation  between  periodontitis  and  LF  titers 
in GCF and blood.8,10 LF is known as a prominent 
component of PMNs and is released in infected 
tissues  and  blood  during  the  inflammatory 
process.  Suomalainen  et  al10  found  increased 
amounts of LF in GCF and peripheral blood PMNs, 
in  localized  juvenile  periodontitis.  Furthermore, 
lower levels of LF was found in periodontitis sites 
during periodontal therapy, and this was followed 
by a rapid resumption to normal levels observed 
in healthy controls. In another study conducted by 
Martins et al,8 the results showed that LF titers 
in  sputum,  gingival  swabs,  and  blood  correlate 
with  the  presence  of  inflammation.  Although 
there are some data about plasma levels of LF at 
periodontitis, our present study appears to be the 
first one to examine plasma levels of LF during the 
experimental gingivitis.
In the present study, our data showed that LF-
BL increased from day 0 to 14, decreased from day 
14 to 35, and finally reached almost the baseline 
values at day 35, the end of the recovery period. 
Although  statistical  analysis  failed  to  detect 
significant  positive  correlation  between  clinical 
scores or LF-GCF and LF-BL at days 0 and 14, still 
the patterns of LF-BL seemed to be compatible 
with LF-GCF, PI, GI and BOP scores at baseline, 
end  of  the  experimental  gingivitis  and  recovery 
periods.  Significant  negative  correlation  (P<.05) 
was detected at day 14 between LF-BL and BOP. 
On the other hand, significant positive correlation 
existed between LF-BL and PI, GI and BOP at day 
35  (P<.05)  which  suggested  that  recovery  from 
gingivitis has significant influences on  LF-BL.   
The  pattern  of  neutrophil  protease  LF 
within  plasma  might  simply  be  associated  with 
momentary  release  of  LF  from  the  specific 
granules of activated neutrophils by local bacterial 
insult, such as the pattern of LF-GCF levels.6,7 On 
the other hand, insignificance of plasma LF level 
alteration during the experimental and recovery 
period might be related with common description 
of  gingivitis  as  “a  local  phenomenon”  in  which 
migration of neutrophils into the oral cavity, via 
the gingival crevicular fluid increases, as part of 
the inflammatory response. This process provides 
the first line of cellular host defence to localize 
the oral flora and possibly reduce the likelihood 
of systemic spread. Moreover, it can be claimed 
that  both  statistically  insignificant  plasma  and 
significant  LF-GCF  alterations  during  the  same 
time  courses,  considered  with  likeness  of  their 
increasing  and  decreasing  patterns,  might  be 
attributed  to  the  effectiveness  of  the  first  line 
of host defence for avoiding systemic spread in 
systemically healthy individuals. 
In  addition,  it  is  known  that  serum  levels 
of  neutrophil  proteases,  such  as  LF  and  PMN-
elastase, have been associated with several mild to 
moderate inflammatory conditions, such as male 
genital track inflammation and Helicobacter pylori 
infection.34-36 It was demonstrated that LF serum 
levels  boost  up  to  higher  levels  within  30-120 
min of intravenous infusion of lipopolysaccharide 
or alive Escherichia coli, in vivo.37 Furthermore, 
not  only  bacterial  contamination,  also  intense 
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physical exercise and stress shown to be effective 
on induction of neutrophil activation, as manifested 
by  release  of  protease  content  of  neutrophil 
granules.38,39 Even if systemic health was one of 
the inclusion criteria of our study, still LF-BL might 
be affected from existence of minor undiagnosed 
inflammations  or  even  from  intense  physical 
exercise.
concLusIons
In  conclusion,  the  data  of  the  present  study 
demonstrated that the local inflammation created 
by plaque accumulation during the experimental 
gingivitis model caused elevated LF levels of GCF 
and  blood.  Furthermore,  the  treatment  of  local 
inflammation and returning to daily oral hygiene 
procedures caused reduction of LF levels in both 
GCF  and  BL.  However,  only  LF-GCF  alterations 
were appeared to be statistically significant, in this 
short term study.  Within the limits of this study, 
our present data contributes to the hypothesis that 
not only periodontitis, also local microbial dental 
plaque accumulation and so caused local gingival 
inflammation might have systemic influences by 
means of LF release from activated neutrophils. 
Moreover, further investigations will help better 
understanding  of  the  possible  extents  of  the 
potential systemic effects of gingivitis. 
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